Senior FDA officials to step down over disagreement with White House on booster shots

From Fox Business:

In a statement to CNBC, the FDA said that Marion Gruber, director of the agency’s Office of Vaccines Research and Review, and her deputy director, Phil Krause, will leave in October and November, respectively.

The duo was reportedly frustrated that the CDC and Advisory Committee on Immunization Practices (ACIP) was spearheading decisions that should be the responsibility of the FDA, the biotech news outlet Endpoint News reported, citing a former senior FDA leader as its source.

The source said that Gruber and Krause finally decided to step down after the Biden administration went ahead with a booster program starting the week of September 20 – without FDA approval.

Share this post

Leave a Reply

Your email address will not be published.